JP2015528435A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528435A5
JP2015528435A5 JP2015525727A JP2015525727A JP2015528435A5 JP 2015528435 A5 JP2015528435 A5 JP 2015528435A5 JP 2015525727 A JP2015525727 A JP 2015525727A JP 2015525727 A JP2015525727 A JP 2015525727A JP 2015528435 A5 JP2015528435 A5 JP 2015528435A5
Authority
JP
Japan
Prior art keywords
pyrazol
carboxamide
indazole
tetrahydro
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015525727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528435A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2013/081136 external-priority patent/WO2014023258A1/en
Publication of JP2015528435A publication Critical patent/JP2015528435A/ja
Publication of JP2015528435A5 publication Critical patent/JP2015528435A5/ja
Pending legal-status Critical Current

Links

JP2015525727A 2012-08-10 2013-08-09 ピラゾールカルボキサミド化合物、組成物及び使用方法 Pending JP2015528435A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261682063P 2012-08-10 2012-08-10
US61/682,063 2012-08-10
US201361764434P 2013-02-13 2013-02-13
US61/764,434 2013-02-13
US201361764930P 2013-02-14 2013-02-14
US61/764,930 2013-02-14
PCT/CN2013/081136 WO2014023258A1 (en) 2012-08-10 2013-08-09 Pyrazole carboxamide compounds, compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2015528435A JP2015528435A (ja) 2015-09-28
JP2015528435A5 true JP2015528435A5 (https=) 2016-06-30

Family

ID=50067432

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015525727A Pending JP2015528435A (ja) 2012-08-10 2013-08-09 ピラゾールカルボキサミド化合物、組成物及び使用方法

Country Status (13)

Country Link
US (2) US20150158851A1 (https=)
EP (1) EP2882718A4 (https=)
JP (1) JP2015528435A (https=)
KR (1) KR20150041651A (https=)
CN (1) CN104781238A (https=)
AR (1) AR092088A1 (https=)
BR (1) BR112015002938A2 (https=)
CA (1) CA2880232A1 (https=)
HK (1) HK1212344A1 (https=)
MX (1) MX2015001864A (https=)
RU (1) RU2015106013A (https=)
TW (1) TW201410654A (https=)
WO (1) WO2014023258A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201706102D0 (en) * 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
WO2019195810A2 (en) * 2018-04-06 2019-10-10 Praxis Biotech LLC Atf6 inhibitors and uses thereof
MX2022007518A (es) 2019-12-20 2022-09-19 Pfizer Derivados bencimidazol.
US20250002489A1 (en) * 2021-10-19 2025-01-02 Nurix Therapeutics, Inc. Bifunctional compounds for degrading itk via ubiquitin proteosome pathway

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0113697A (pt) * 2000-09-06 2003-07-22 Neurogen Corp Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou sal, embalagem e métodos para, para alterar a atividade transdutora de sinal dos receptores de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, para demonstrar a presença dos receptores de gabaa em células ou amostras de tecido e para preparar um composto
WO2003037900A2 (en) * 2001-11-01 2003-05-08 Icagen, Inc. Pyrazolopyrimidines
BR0307504A (pt) * 2002-02-07 2004-12-07 Neurogen Corp Composto ou sal farmaceuticamente aceitável, composição farmacêutica, métodos tratar doenças, para potencializar um efeito terapêutico de um agente para o snc, para melhorar a memória de curto prazo em um paciente, para determinar a presença ou ausência de receptores gabaa em uma amostra, e para alterar a atividade transdutora de sinal do receptor gabaa, embalagem, e, uso de um composto ou sal
FR2845382A1 (fr) * 2002-10-02 2004-04-09 Sanofi Synthelabo Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
EP1960382A1 (en) * 2005-11-03 2008-08-27 ChemBridge Research Laboratories, Inc. Heterocyclic compounds as tyrosine kinase modulators
UA110324C2 (en) * 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
US9073926B2 (en) * 2009-12-07 2015-07-07 Boehringer Ingelheim International Gmbh Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
AU2011329233A1 (en) * 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
CN103889976A (zh) * 2011-08-12 2014-06-25 弗·哈夫曼-拉罗切有限公司 吲唑化合物、组合物及使用方法

Similar Documents

Publication Publication Date Title
JP2013523884A5 (https=)
JP2021502356A5 (https=)
JP2025535046A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
TWI793191B (zh) P38激酶抑制劑減少dux4及下游基因表現以供治療fshd
JP2022500402A5 (https=)
JP2018536671A5 (https=)
JP2017193592A5 (https=)
JP2012532931A5 (https=)
JP2010510319A5 (https=)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2019523233A5 (https=)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2015522002A5 (https=)
JP2013545779A5 (https=)
RU2019132212A (ru) Селективные ингибиторы hdac6
SI3008053T1 (en) PHOSPHATIDYLINOSITOL 3-KINATE INHIBITORS
JP2020526549A5 (https=)
JP2017508763A5 (https=)
JP2019514903A5 (https=)
JP2021533179A5 (https=)
JP2016523976A5 (https=)
JP2014503544A5 (https=)
JP2018508553A5 (https=)
JP2013531070A5 (https=)
JP2020520925A5 (https=)